__________________________________________________________________________________________
Re: Local ID TH130904132 / TH201310001362 FU (3)
Thank you for reporting to us an adverse event related to Lilly product.
We would like to collect more information to better understanding the reported event.
Please respond to following questions regarding the adverse event – Dizziness and pain on leg involving female patient , 78 yrs who was subscribed Forteo, reported the event to Lilly on 30/SEP/2013.
Please follow up for the following:
1. When patient start unspecified pain medication? What was this medication?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
2. Did the patient undergo any exam?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
3. What was teriparatide and unspecified pain medication status?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
Thanks
Yours sincerely,
ELI LILLY AND COMPANY
Sasithorn Suntharo
Pharmacovigilance Associate
HCP’s signature:
Date:
__________________________________________________________________________________
For Eli Lilly internal use only
Date of Confirmation of FU request sent to HCP:
Name and Designation: